Law360, New York (June 08, 2012, 7:08 PM ET) -- The U.S. Food and Drug Administration announced Friday that its drug safety advisory committee will consider restricting access to the painkiller hydrocodone by moving it to a higher class of controlled substances, a move the government has been privately mulling for more than a decade.
The committee will hold a public meeting at the end of October to look at the public health benefits and risks of hydrocodone, the country's most prescribed drug and one of the most abused. The Drug Enforcement Administration asked the FDA...